Tau Imaging in Neurodegenerative Diseases Using Positron Emission Tomography
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tau Imaging in Neurodegenerative Diseases Using Positron Emission Tomography
Authors
Keywords
Positron emission tomography, Tau, Neurofibrillary tangles, Dementia, Neurodegenerative diseases, Neurodegeneration
Journal
Current Neurology and Neuroscience Reports
Volume 19, Issue 7, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-06-06
DOI
10.1007/s11910-019-0962-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Longitudinal tau PET in ageing and Alzheimer’s disease
- (2018) Clifford R Jack et al. BRAIN
- Dual tracer tau PET imaging reveals different molecular targets for 11C-THK5351 and 11C-PBB3 in the Alzheimer brain
- (2018) Konstantinos Chiotis et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- In vivo characterization and quantification of neurofibrillary tau PET radioligand [18F]MK-6240 in humans from Alzheimer’s disease dementia to young controls
- (2018) Tobey J Betthauser et al. JOURNAL OF NUCLEAR MEDICINE
- The Merits of FDDNP-PET Imaging in Alzheimer's Disease
- (2018) Jonghan Shin et al. JOURNAL OF ALZHEIMERS DISEASE
- A Highly Selective and Specific PET Tracer for Imaging of Tau Pathologies
- (2018) Wei Zhang et al. JOURNAL OF ALZHEIMERS DISEASE
- Early Clinical PET Imaging Results with the Novel PHF-Tau Radioligand [F-18]-T807
- (2018) David T. Chien et al. JOURNAL OF ALZHEIMERS DISEASE
- Early Clinical PET Imaging Results with the Novel PHF-Tau Radioligand [F18]-T808
- (2018) David T. Chien et al. JOURNAL OF ALZHEIMERS DISEASE
- Evaluation of18F-RO-948 (18F-RO6958948) for quantitative assessment of tau accumulation in the human brain with positron emission tomography
- (2018) Hiroto Kuwabara et al. JOURNAL OF NUCLEAR MEDICINE
- In vivo quantification of neurofibrillary tangles with [18F]MK-6240
- (2018) Tharick A. Pascoal et al. Alzheimers Research & Therapy
- Greater tau load and reduced cortical thickness in APOE ε4-negative Alzheimer’s disease: a cohort study
- (2018) Niklas Mattsson et al. Alzheimers Research & Therapy
- Head to head comparison of [18F] AV-1451 and [18F] THK5351 for tau imaging in Alzheimer’s disease and frontotemporal dementia
- (2017) Young Kyoung Jang et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Identification of Three Novel Radiotracers for Imaging Aggregated Tau in Alzheimer’s Disease with Positron Emission Tomography
- (2017) Luca C. Gobbi et al. JOURNAL OF MEDICINAL CHEMISTRY
- Off-Target18F-AV-1451 Binding in the Basal Ganglia Correlates with Age-Related Iron Accumulation
- (2017) Jae Yong Choi et al. JOURNAL OF NUCLEAR MEDICINE
- Preclinical Evaluation of18F-RO6958948,11C-RO6931643, and11C-RO6924963 as Novel PET Radiotracers for Imaging Tau Aggregates in Alzheimer Disease
- (2017) Michael Honer et al. JOURNAL OF NUCLEAR MEDICINE
- Current Understanding of Neurodegenerative Diseases Associated With the Protein Tau
- (2017) Keith A. Josephs MAYO CLINIC PROCEEDINGS
- Tau PET imaging: present and future directions
- (2017) Laure Saint-Aubert et al. Molecular Neurodegeneration
- The tau positron-emission tomography tracer AV-1451 binds with similar affinities to tau fibrils and monoamine oxidases
- (2017) Céline Vermeiren et al. MOVEMENT DISORDERS
- In vivo retention of 18 F-AV-1451 in corticobasal syndrome
- (2017) Ruben Smith et al. NEUROLOGY
- Comparative binding properties of the tau PET tracers THK5117, THK5351, PBB3, and T807 in postmortem Alzheimer brains
- (2017) Laetitia Lemoine et al. Alzheimers Research & Therapy
- Monoamine oxidase B inhibitor, selegiline, reduces 18F-THK5351 uptake in the human brain
- (2017) Kok Pin Ng et al. Alzheimers Research & Therapy
- The Changing Landscape of Neuroscience Research, 2006–2015: A Bibliometric Study
- (2017) Andy Wai Kan Yeung et al. Frontiers in Neuroscience
- Tau neuropathology correlates with FDG-PET, but not AV-1451-PET, in progressive supranuclear palsy
- (2016) Ruben Smith et al. ACTA NEUROPATHOLOGICA
- EVALUATION OF TAU BURDEN IN A CROSS-SECTIONAL COHORT OF ALZHEIMER’S DISEASE SUBJECTS USING [18F]GTP1 (GENENTECH TAU PROBE 1)
- (2016) Sandra Sanabria Bohorquez et al. Alzheimers & Dementia
- Tau mis-splicing in the pathogenesis of neurodegenerative disorders
- (2016) Sun Ah Park et al. BMB Reports
- 18F-AV-1451 tau PET imaging correlates strongly with tau neuropathology inMAPTmutation carriers
- (2016) Ruben Smith et al. BRAIN
- Discovery of 6-(Fluoro-18F)-3-(1H-pyrrolo[2,3-c]pyridin-1-yl)isoquinolin-5-amine ([18F]-MK-6240): A Positron Emission Tomography (PET) Imaging Agent for Quantification of Neurofibrillary Tangles (NFTs)
- (2016) Abbas M. Walji et al. JOURNAL OF MEDICINAL CHEMISTRY
- Modeling Strategies for Quantification of In Vivo 18 F-AV-1451 Binding in Patients with Tau Pathology
- (2016) Andreas Hahn et al. JOURNAL OF NUCLEAR MEDICINE
- Preclinical Characterization of 18F-MK-6240, a Promising PET Tracer for In Vivo Quantification of Human Neurofibrillary Tangles
- (2016) E. D. Hostetler et al. JOURNAL OF NUCLEAR MEDICINE
- Increased basal ganglia binding of18F-AV-1451 in patients with progressive supranuclear palsy
- (2016) Ruben Smith et al. MOVEMENT DISORDERS
- In vivo visualization of tau deposits in corticobasal syndrome by 18 F-THK5351 PET
- (2016) Akio Kikuchi et al. NEUROLOGY
- Imaging biomarkers in tauopathies
- (2016) Melanie Dani et al. PARKINSONISM & RELATED DISORDERS
- Comparison of New Tau PET-Tracer Candidates With [18F]T808 and [18F]T807
- (2016) Lieven Declercq et al. Molecular Imaging
- First in-human PET study of 3 novel tau radiopharmaceuticals: [11C]RO6924963, [11C]RO6931643, and [18F]RO6958948
- (2015) Dean F. Wong et al. Alzheimers & Dementia
- [18F]THK-5117 PET for assessing neurofibrillary pathology in Alzheimer’s disease
- (2015) Ryuichi Harada et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- 18F-THK5351: A Novel PET Radiotracer for Imaging Neurofibrillary Pathology in Alzheimer Disease
- (2015) R. Harada et al. JOURNAL OF NUCLEAR MEDICINE
- Non-invasive assessment of Alzheimer’s disease neurofibrillary pathology using 18F-THK5105 PET
- (2014) Nobuyuki Okamura et al. BRAIN
- Tau PET Imaging in Alzheimer’s Disease
- (2014) Nobuyuki Okamura et al. Current Neurology and Neuroscience Reports
- In vivo evaluation of a novel tau imaging tracer for Alzheimer’s disease
- (2014) Victor L. Villemagne et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Molecular Imaging Insights into Neurodegeneration: Focus on Tau PET Radiotracers
- (2014) M. Shah et al. JOURNAL OF NUCLEAR MEDICINE
- Assessing THK523 selectivity for tau deposits in Alzheimer’s disease and non–Alzheimer’s disease tauopathies
- (2014) Michelle T Fodero-Tavoletti et al. Alzheimers Research & Therapy
- [18F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease
- (2013) Chun-Fang Xia et al. Alzheimers & Dementia
- Novel 18F-Labeled Arylquinoline Derivatives for Noninvasive Imaging of Tau Pathology in Alzheimer Disease
- (2013) N. Okamura et al. JOURNAL OF NUCLEAR MEDICINE
- Tau pathology and neurodegeneration
- (2013) Maria Grazia Spillantini et al. LANCET NEUROLOGY
- [11C]PBB3—a new PET ligand that identifies tau pathology in the brains of patients with AD
- (2013) Heather Wood Nature Reviews Neurology
- Imaging of Tau Pathology in a Tauopathy Mouse Model and in Alzheimer Patients Compared to Normal Controls
- (2013) Masahiro Maruyama et al. NEURON
- Neuropathological Alterations in Alzheimer Disease
- (2013) A. Serrano-Pozo et al. Cold Spring Harbor Perspectives in Medicine
- Comparison of the binding characteristics of [18F]THK-523 and other amyloid imaging tracers to Alzheimer’s disease pathology
- (2012) Ryuichi Harada et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- 18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease
- (2011) M. T. Fodero-Tavoletti et al. BRAIN
- First ever longitudinal [ 11C ]PIB and [ 18 F]FDDNP PET studies in patients with Alzheimer's disease or mild cognitive impairment and healthy controls
- (2010) Rik Ossenkoppele et al. Alzheimers & Dementia
- Tau exon 10 alternative splicing and tauopathies
- (2008) Fei Liu et al. Molecular Neurodegeneration
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started